|Author(s)/Faculty: Lawrence Blonde, MD, FACP, FACE; Samuel Dagogo-Jack, MD, FRCP; Alan J. Garber, MD, PhD; George Grunberger, MD, FACP, FACE|
|Source: Healio - Endocrinology Education Lab|
|Type: Multimedia||Articles/Items: 3|
|Release Date: 10/11/2013||Expiration Date: 10/11/2014|
|Credit Type: CME||Number of Credits: 1.75|
|Cost: Free||Provider: |
|This CME activity is based on the slides and lectures presented by the faculty at the symposium, The Enduring Challenge of T2DM ─ Assessing Current Tools to Optimize Patient Outcomes, on May 1, 2013, in Phoenix, Arizona. |
New developments in pharmacology and improved understanding of pathophysiology have led to refinements of recommended treatment algorithms. In type 2 diabetes mellitus (T2DM), research has shown the importance of the interrelationship of diabetes and cardiovascular risk. By considering these elements in concert when developing management strategies, clinicians may be able to achieve better outcomes for their patients. In this activity, leading clinicians will discuss how revisions to treatment algorithms will affect patient care, the rationale behind their development and their implementation by presenting state of the science data, and discussing them in the context of real-world cases.